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ABstrAct
Objectives Bone destruction in rheumatoid arthritis is 
mediated by osteoclasts (oC), which are derived from 
precursor cells of the myeloid lineage. the role of the 
two monocyte subsets, classical monocytes (expressing 
Cd115, Ly6C and CCr2) and non-classical monocytes 
(which are Cd115 positive, but low in Ly6C and CCr2), 
in serving as precursors for oC in arthritis is still elusive.
Methods We investigated CCr2−/− mice, which lack 
circulating classical monocytes, crossed into htnFtg mice 
for the extent of joint damage. We analysed monocyte 
subsets in htnFtg and K/Bxn serum transfer arthritis 
by flow cytometry. We sorted monocyte subsets and 
analysed their potential to differentiate into oC and 
their transcriptional response in response to rAnKL by 
rnA sequencing. With these data, we performed a gene 
ontology enrichment analysis and gene set enrichment 
analysis.
results We show that in htnFtg arthritis local bone 
erosion and oC generation are even enhanced in the 
absence of CCr2. We further show the numbers of 
non-classical monocytes in blood are elevated and are 
significantly correlated with histological signs of joint 
destruction. Sorted non-classical monocytes display 
an increased capacity to differentiate into oCs. this 
is associated with an increased expression of signal 
transduction components of rAnK, most importantly 
trAF6, leading to an increased responsiveness to 
rAnKL.
conclusion therefore, non-classical monocytes are 
pivotal cells in arthritis tissue damage and a possible 
target for therapeutically intervention for the prevention 
of inflammatory joint damage.
IntrOductIOn
In patients with inflammatory arthritis, joint 
destruction is the most serious consequence of 
the disease, as it leads to irreversible functional 
impairment.1 2 Destruction of the articular bone 
has been demonstrated to be almost exclusively 
mediated by osteoclasts (OC), multinucleated 
cells of myeloid origin generated from monocytic/
macrophage like precursors, which are still poorly 
defined.3–7 
The importance of OC in erosive arthritis 
has been shown in various experimental murine 
models; in the absence of receptor activator NF-κB 
ligand (RANKL) or c-fos, arthritic mice are fully 
protected against bone damage despite the presence 
of severe synovial inflammation.4 6 The life span of 
individual OC has been estimated to be only a few 
weeks; therefore, they have to be replaced by a 
perpetual supply of osteoclast precursors (pOCs).8 
Peripheral blood monocytes are potential precur-
sors for OC, as both in humans and in mice mono-
cytes can be driven to differentiate into OCs on 
stimulation with M-CSF and RANKL and increased 
frequencies of potential pOCs have been identified 
in patients with inflammatory arthritides.3 8–11 
Based on the expression of lymphocyte antigen 6 
complex (Ly6C) and chemokine receptor 2 (CCR2) 
monocytes can be further subdivided into inflam-
matory or classical monocytes expressing CD11b, 
CD115, Ly6C and CCR2 and resident or non-clas-
sical monocytes, which do not express Ly6C and 
CCR212–14. The chemokine receptor CCR2 has 
been shown to be important in the biology of 
inflammatory monocytes, as mice lacking this 
receptor show greatly reduced numbers of circu-
lating inflammatory monocytes.15 16 CCR2-defi-
cient mice have been used in several experimental 
models of autoinflammatory/autoimmune diseases 
to show that classical monocytes are the culprits 
of pathology that mediate tissue damage, since 
CCR2-deficient mice were protected against 
these diseases.17–19 However, in arthritis, the role 
of monocyte subsets is controversial. It is known 
that haematopoietic cells including monocytes are 
recruited to the site of inflammation and differ-
entiate into macrophages and OCs locally in the 
synovial membrane.20 However, it is still unclear 
if there are committed pOCs or if all monocytes/
macrophages have the potential to become OCs. In 
this regard, the role of the two monocyte subsets in 
mediating joint destruction and in particular their 
role as pOCs during arthritis is conflicting, as some 
reports showed an important role of CCR2+ cells 
and thus classical monocytes as OC precursors in 
arthritis as well as osteoporosis, whereas others 
claimed non-classical monocytes to be critically 
important for joint inflammation.21–23 Of particular 
note, CCR2-deficient mice develop more severe 
(and more destructive) arthritis in several experi-
mental models.21 22 24–26
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MAterIAls And MetHOds
Animals and arthritis models
The heterozygous human TNF transgenic (hTNFtg) Tg197 
mouse strain has been described previously.27 CCR2 -/- mice on 
the C57bl/6 genetic background were purchased from Jackson 
Laboratories and crossed into hTNFtg animals. Arthritis was 
evaluated weekly in a blinded manner as described previously.6
Serum-transfer arthritis was induced by intraperitoneal 
application of 150 µl of K/BxN serum on day 0 and day 2 as 
described.28
All animal studies were approved by the animal ethics 
committee of the Medical University Vienna and comply with 
institutional guidelines.
Histology and immunohistochemistry
Histological sections of hind paws from wild type (WT) hTNFtg 
and hTNFtg/CCR2−/− mice, serum transfer arthritis as well as 
the Tissue Quest analysis were prepared and analysed as previ-
ously described.6 20 28 29
Flow cytometry and cell sorting
Blood was collected every other week starting at 4 weeks of age 
until the end of the experiment (week 10 for hTNFtg, day 12 
for K/BxN serum transfer arthritis). Cells were simultaneously 
stained for CD11b (PerCP-Cy5.5-conj., clone M1/70), CD115 
(PE-conj., clone AFS98) Ly6-G (FITC-conj., clone RB6-8C5, 
all eBioscience) and Ly6-C (PE-Cy7-conj., clone AL-21) and 
CD11c (APC-Cy7-conj., clone HL3, all BD Pharmingen). Clas-
sical monocytes were characterised as CD11b+CD115+Ly6C+ 
and non-classical monocytes as CD11b+CD115+Ly6C- cells. 
For flow-cytometric analyses, we used a BD FACSCanto II 
(Becton Dickinson Immunocytometry Systems, San Jose, 
California, USA).
For cell sorting, pooled peripheral blood cells from either 
hTNFtg or WT mice were stained with CD11b, CD115 and 
Ly6-C antibodies and then isolated using a BD FACSAria II 
sorter.
In vitro Oc generation
For in vitro OC formation, we sorted classical and non-clas-
sical monocytes from WT or arthritic hTNFtg mice. Cells were 
cultured in MEM-alpha supplemented with 10% fetal bovine 
serum (FBS) in the presence of 100 ng/mL M-CSF for 3 days, 
then MEM-alpha with 10% FBS and 30 ng/mL M-CSF and 
50 ng/mL RANKL. After 4 days, we performed tartrate-resistant 
acid phosphatase (TRAP) staining and determined the amount of 
OCs (TRAP positive and three or more nuclei) and also counted 
the numbers of nuclei.
rnA-sequencing
Total RNA was prepared from approximately 1 million WT clas-
sical and non-classical monocytes by using mirVana miRNA 
Isolation Kit (AM1560, ABI). Two hundred nanograms of 
total RNA was subsequently used to prepare RNA-seq library 
by using TruSeq SR RNA sample prep kit (FC-122–1001, Illu-
mina), following the manufacturer’s protocol. The libraries 
were sequenced for 50 cycles (single read) with a HiSeq 2000 
(Illumina). Raw sequencing data were processed with CASAVA 
1.8.2 to generate FastQ files. Sequence reads were mapped onto 
the mouse genome build mm9 using TopHat 2.0. Gene expres-
sion values (RPKM, reads per kilobase exon per million mapped 
reads) were calculated with Cufflinks 2.0. All downstream 
statistical analyses, including PCA, were performed with Partek 
Genomics Suite 6.6, R 3.0.1 and GeneSpring GX 12.1 (Agilent 
Technologies).
Western blotting
Sorted classical and non-classical monocytes were cultured in 
the presence of 100 ng/mL M-CSF for 3 days or an additional 
24 hours with RANKL (DC-STAMP) and then lysed in radioim-
munoprecipitation (RIPA) buffer supplemented with phospha-
tase and protease inhibitors (Roche). Western blotting (WB) was 
performed as described.29 Primary antibodies used: Actin (Cyto-
skeleton), TRAF6 (Santa Cruz), DC-STAMP (Merck).
GO term enrichment analysis
Functional gene annotations were obtained from the Gene 
Ontology (GO) database.30 31 Gene set enrichment analyses 
were performed using Fisher's exact test with all approved 
protein coding genes from the HUGO Gene Nomenclature 
Figure 1 hTNFtg/CCR2−/−-deficient mice showed enhanced local bone 
destruction and osteoclast formation. CCR2−/− mice were crossed into 
hTNFtg mice and histological analysis was performed. (A) Quantitative 
analysis of histological parameters of arthritis (hTNFtg, n=5; hTNFtg/
CCR2−/−, n=9)). Results are shown as mean±SEM (B) Representative 
histological sections of the hind paws of hTNFtg/CCR2+/+ and hTNFtg/
CCR2−/− mice stained with H&E and TRAP. Osteoclasts are displayed as 
purple-stained cells. *P<0.05. (C), Analysis of the percentage of Ly6C+ 
cells (left panel), CD115+ cells (middle panel) and Gr1+ cells (right 
panel) shown as per cent of total cells in the synovial membrane of 
hTNFtg/CCR2+/+ and hTNFtg/CCR2−/− mice. TRAP, tartrate-resistant acid 
phosphatase.
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Committee (HGNC) as background set.32 The resulting p values 
were corrected for multiple hypotheses testing according to the 
Bonferroni procedure using a cut-off of p<0.05. In order to 
remove redundant GO terms, we summarised all terms with a 
semantic similarity of 0.7 or higher and represented them by 
their most informative common ancestor with the GO tree.
statistical analysis
Data are presented as the means±SEM. We compared group 
mean values, as appropriate, by Student’s unpaired two-tailed 
t-test or one-way analysis of variance with Bonferroni’s 
multiple comparison test (Graph Pad Prism). We considered 
p<0.05 significant.
results
Increased joint damage in ccr2-deficient htnFtg mice
CCR2 deficiency has been shown to aggravate arthritis in 
interleukin1 receptor antagonist (IL1-RA)−/− mice as well as 
in collagen-induced arthritis (CIA).25 26 In our first experiment 
we tested, whether reduction of circulating classical mono-
cytes altered the extent of arthritis and joint damage also in 
hTNFtg mice. To this end, we crossed CCR2-deficient mice 
into hTNFtg mice, generating hTNFtg/CCR2−/− mice. We 
detected increased synovial inflammation (figure 1), consistent 
with the results obtained in other models of arthritis. hTNFtg/
CCR2−/− mice also showed a significant increase in the extent 
of erosive bone damage and local generation of OC compared 
with hTNFtg mice (figure 1A, B). Analysing the composition of 
the inflammatory infiltrate, we detected only few Ly6C+ cells 
in the inflamed synovium (figure 1C). There were numerically 
increased numbers of CD115+ cells but fewer Gr1+ neutrophil 
granulocytes in hTNFtg/CCR2−/− mice compared with hTNFtg 
mice (figure 1C). Of note, we detected a significant retention 
of Ly6C+ cells in the bone marrow of hTNFtg/CCR2−/− mice, 
in accordance with the published phenotype of CCR2-deficient 
mice (online supplementary figure S1). Therefore, although 
Ly6C+ cells are retained in the bone marrow also in the hTNFtg 
model in CCR2-deficient mice, tissue damage is not reduced, but 
even enhanced.
non-classical monocytes are elevated in htnFtg arthritis
We next analysed the relative numbers of myeloid cells in blood 
and spleens of WT and hTNFtg mice by flow cytometry. We 
detected significantly increased proportions of CD11b+ myeloid 
cells and CD115+ monocytes in blood and spleens of hTNFtg 
compared with WT mice (figure 2B, C). Both CD11b+C-
D115+Ly6C+ classical and CD11b+CD115+Ly6C- non-clas-
sical monocytes were significantly elevated in blood and spleen, 
suggesting altered composition of myeloid cells in hTNFtg mice 
(figure 2B, C). In hTNFtg mice, arthritis can be detected around 
week 5 of age (figure 3A). We therefore analysed blood of mice 
starting at 4 weeks of age, when no clinical symptoms of arthritis 
are detectable. We found that total numbers of CD115+ mono-
cytes were significantly increased compared with WT animals 
already at 4 weeks of age and remained elevated at every time 
point measured (week, 4, 6, 8 and 10) (figure 3B). Analysing 
classical monocytes, we found a significant increase of these cells 
only from week 6 onwards. Non-classical monocytes, however, 
Figure 2 Monocytes in blood and spleen in hTNFtg arthritis. (A) Gating of flow cytometric analysis of myeloid populations in blood obtained from 
WT and hTNFtg mice. (B,C) Bar graph summarising frequencies of myeloid populations in blood (B) and spleen (C) of WT mice and hTNFtg mice 
(n=at least 10 per group). Results are shown as mean±SEM. **P<0.01; ***P<0.001. WT, wild type. 
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were increased in hTNFtg mice throughout the observation 
period, beginning from week 4 (figure 3B). These data reveal, 
that in arthritis prone hTNFtg mice, non-classical monocytes are 
increased already at the preclinical stage.
Moreover, when we plotted levels of classical or non-classical 
monocytes in blood against the number of OC found in the hind 
paws of arthritic mice, we detected a significant correlation 
between the number of non-classical monocytes in blood and 
the number of OCs in hind paws (r=0.64, p=0.02). Further, 
the levels of these cells correlated with the area of inflammatory 
bone destruction (r=0.66, p=0.01; figure 4A) and the area of 
synovial inflammation (r=0.65, p=0.02; figure 4A). In contrast, 
none of these variables correlated significantly with the number 
of classical monocytes in peripheral blood (figure 4B).
non-classical monocytes accumulate at the site of tissue 
damage
We next asked, how Ly6C+ cells were distributed in the inflamed 
synovial membrane and compared this to the general distribu-
tion of CD115+ cells. While we did detect Ly6C+ cells in the 
arthritic synovial membrane of hTNFtg mice, there were almost 
no Ly6C+ cells in the vicinity of erosions (figure 4C). More-
over, OCs stained negative for Ly6C. However, erosions were 
packed with CD115+ cells, with OCs also expressing CD115. 
Altogether these data reveal, that OCs in vivo are negative for 
Ly6C and that also the monocytes/macrophages present in the 
vicinity of OCs are negative for Ly6C.
To validate the data obtained in hTNFtg animals, we used 
another arthritis model, namely K/BxN serum transfer arthritis.33 
While we did not detect increased relative numbers of CD11b+ 
cells or CD115+ cells in blood or spleens after induction of K/
BxN serum transfer arthritis (online supplementary figure S2), 
relative numbers of non-classical monocytes in blood positively 
correlated with markers of joint destruction (area of erosion 
and number of OCs) (online supplementary figure S3A). Again, 
the relative numbers of classical monocytes in blood did not 
correlate with area of inflammation, area of erosion or number 
of OC in the hind paw (online supplementary figure S3B). These 
findings further demonstrate a close correlation of non-classical 
monocytes with various parameters of bone destruction. We also 
stained for CD115 and Ly6C in the inflamed hind paws of mice 
after induction of K/BxN serum transfer arthritis. In line with the 
hTNFtg model, we detected CD115+ monocytes in the vicinity 
of bone erosions also in K/BxN serum transfer arthritis (online 
supplementary figure S3C) and OC stained negative for Ly6C.
High osteoclastogenic potential of non-classical monocytes 
ex vivo
In order to test the osteoclastogenic potential of the two mono-
cyte subsets, we isolated classical monocytes and non-classical 
monocytes from blood by FACS and cultured these cells with 
M-CSF and RANKL. Non-classical monocytes were significantly 
more potent in differentiating into mature multinucleated OCs 
than classical monocytes, irrespective of whether the monocytes 
derived from WT or arthritic hTNFtg mice (figure 5A). In order 
to investigate potential mechanisms related to the increased 
osteoclastogenic potential of non-classical monocytes compared 
with classical monocytes, we tested the global transcriptional 
response of both monocyte subpopulations to RANKL stimula-
tion. Therefore, we performed RNA sequencing of non-classical 
monocytes and classical monocytes after 24 hours of RANKL 
stimulation. Transcriptome analysis revealed a large number of 
differentially regulated genes (figure 5B,C). In a gene set enrich-
ment analysis, we detected statistically significant enrichment 
of all RANKL-induced genes in categories such as metabolic 
pathways, genes involved in growth, chemotaxis and prolifer-
ation as well as OC associated molecular markers in stimulated 
non-classical monocytes compared with classical monocytes.34 
Figure 3 Development of arthritis is accompanied by accumulation of circulating mononuclear cells. (A) Clinical assessment of paw swelling and 
grip strength in WT mice (n=10) and hTNFtg mice (n=9). (B) Characterisation of monocytes under steady-state conditions and during hTNF driven 
arthritis. Blood from WT mice and hTNFtg were analysed using flow cytometric analysis over time (n=at least 12 per group and time point). Results are 
shown as mean±SEM. *P<0.05; **P<0.01; ***P<0.001. WT, wild type. Protected by copyright.
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Vice versa, RANKL-repressed genes were significantly enriched 
in classical monocytes (online supplementary figure S4).
Gene ontology enrichment analysis showed increased expres-
sion of genes associated with the inflammatory response and 
response to microbial products in classical monocytes compared 
with non-classical monocytes. In contrast, genes associated with 
regulation of OC differentiation, iron metabolism and regulation 
of pH were enriched in non-classical monocytes (figure 5D).
Of note, we found a significantly increased expression of 
TRAF6 and Gab2, both proximal adaptors of RANK-mediated 
signal transduction with well-established roles in osteoclas-
togenesis,35 36 in non-classical monocytes compared with clas-
sical monocytes (figure 6A). Increased expression of TRAF6 
in non-classical monocytes versus classical monocytes was 
confirmed by qPCR and at the protein levels by Western blot 
(figure 6B and online supplementary figure S5). We did not 
detect differences in c-fms or RANK, the respective receptors 
for M-CSF and RANKL (figure 6C). However, among the 
differentially expressed genes, we found osteoclast-associated 
receptor (OSCAR) as well as Osteoclast Stimulatory Transmem-
brane Protein (OC-Stamp) and dendritic cell-specific transmem-
brane protein (DC-Stamp), the latter being important molecules 
regulating the fusion of OCs (figure 6C).37–39 We confirmed 
increased expression of DC-STAMP on non-classical mono-
cytes by Western Blot (figure 6D). We therefore determined the 
number of nuclei/OC that we found in OCs that had differen-
tiated from non-classical monocytes or classical monocytes. As 
shown in figure 6E and F, OC derived from non-classical mono-
cytes exhibited significantly more nuclei than OCs derived from 
classical monocytes.
dIscussIOn
Elucidating the mechanisms leading to irreversible joint 
damage and consequently functional impairment in patients 
suffering from inflammatory arthritis is of major importance 
for our understanding of the pathways to severe and disabling 
disease and for the development of new and even more effec-
tive remedies for treating these diseases than available today. In 
our study, we provide evidence that tissue damage in arthritis 
is predominantly mediated by non-classical monocytes lacking 
Ly6C.
The importance of different monocyte subsets in specific 
diseases, such as autoimmune/autoinflammatory and infectious 
diseases, has just begun to be appreciated. In many autoim-
mune models, the role of monocyte subsets in causing disease 
seems to be quite clear. In colitis, CCR2+ monocytes have been 
established as culprits for tissue damage.19 40 Similarly, CCR2+ 
cells are the predominant infiltrating myeloid cells type in 
experimental autoimmune encephalomyelitis (EAE) and seem 
Figure 4 Characterisation of monocytes during hTNF driven arthritis. The number of circulating non-classical monocytes (A) and classical monocytes 
(B) was correlated with histological markers of joint destruction such as the number of osteoclasts, the area of erosion and inflammation. (C) H&E 
staining of a hind paw of a hTNFtg mouse (scale bars=1 mm) and immunohistochemical staining for monocyte markers CD115 and Ly6C in an erosion 
(scale bars=50 µm). Arrows indicate CD115 positive osteoclasts.
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to be directly responsible for axonal damage, and CCR2-defi-
cient mice are resistant to EAE.18 41–43 Also in atherosclerosis, 
CCR2 has been found to be essential in lesion generation.17 44
However, the pathogenesis of inflammatory arthritis seems 
to be different. It has been already reported that in both 
CIA as well as arthritis in IL1-RA deficient mice, CCR2 defi-
ciency is associated with an increase in clinical signs and joint 
damage.25 26 In addition, recent evidence also suggests an 
important role of non-classical Ly6C- monocytes in the patho-
genesis of K/BxN serum transfer arthritis, as antibody-medi-
ated depletion of CCR2+ cells or in CCR2 deficiency did not 
alter arthritis development, whereas depletion of monocytes in 
general or specifically of non-classical monocytes ameliorated 
disease.21 However, there have also been reports suggesting 
that Ly6C+ classical monocytes to mediate tissue destruction 
in arthritis.22 Therefore, the exact role of the two monocyte 
subsets is still controversial. Here, we have used two common 
models of inflammatory arthritis. The data obtained show 
positive correlations of non-classical monocytes with histo-
logical parameters of bone destruction in both hTNFtg and 
K/BxN serum transfer arthritis. Of note, we detected only 
small numbers of Ly6C+ cells in hTNFtg synovitis, which is 
in agreement with the flow cytometric analyses of Misharin 
and colleagues in serum transfer arthritis.21 Most importantly, 
Figure 5 Identification of cell populations with osteoclastogenic potential from peripheral blood cells. (A) In vitro OC assay of sorted Ly6C+ classical 
and Ly6C– non-classical monocytes of WT and hTNFtg mice stimulated with MCSF (4d) and RANKL (3d). Graph shows the number of TRAP positive 
multinucleated cells (data shown are mean values of five independent experiments±SEM). (B) Volcano plot representation of differential expression 
analysis of genes in RNA sequencing of WT Ly6C+ classical vs Ly6C– non-classical monocytes after stimulation with MCSF (4d) and RANKL (1d) 
(n=3 each). The x-axis shows log2 FC in expression, the negative log10 of the p value is plotted on the y-axis. Each gene is represented by one point 
on the graph. (C) Number of differentially regulated genes (FC≥2, p≤0.05) in RNA sequencing in Ly6C+ classical vs Ly6C– non-classical monocytes. (D) 
GO enrichment analysis of the transcriptome of Ly6C+ classical vs Ly6C– non-classical monocytes: x-axis shows FC of significantly enriched GO terms 
in differentially regulated genes in RNA-sequencing of Ly6C+ classical vs Ly6C– non-classical monocytes. The number in the columns represents the 
–log10 p value of the indicated GO term. **P<0.01; ***P<0.001. FC, fold change; GO, Gene Ontology; OC, osteoclasts; TRAP, tartrate-resistant acid 
phosphatase; WT, wild type. 
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we demonstrate that non-classical monocytes have a signifi-
cantly increased potential to differentiate into OC. Anal-
ysis of the transcriptional response of these cells to RANKL 
revealed enrichment of genes involved in iron metabolism in 
non-classical monocytes. Intriguingly, osteoclastogenesis has 
been shown to depend on iron, and genes involved in iron 
metabolism have been shown to be essential in the generation 
of OC.45 In general, RANKL-induced genes were enriched in 
non-classical monocytes, suggesting an increased responsive-
ness of non-classical monocytes to RANKL. It will be inter-
esting to bioinformatically compare transcriptional signatures 
obtained by us with monocytes subpopulations.46 In a more 
detailed analysis, we found components of the RANK-associ-
ated signal transduction machinery to be expressed at higher 
levels in non-classical monocytes versus classical monocytes, 
most importantly TRAF6 and Gab2. This observation offers a 
potential molecular explanation for the increased responsive-
ness to RANKL.
Of note, we also found increased levels of markers regulating 
fusion of OC, such as DC-STAMP and OC-STAMP. Indeed 
OCs derived from non-classical monocytes displayed increased 
numbers of nuclei/OC, suggesting increased potential to form 
multinucleated cells compared with non-classical monocytes. 
Interestingly, increased DC-STAMP expression has also been 
noted in human non-classical CD16+ monocytes, and these 
cells have been found to be elevated in RA and psoriatic 
arthritis.47–49
Monocytes are of pivotal importance in arthritis. All 
effective therapies lead primarily to a reduction in synovial 
monocytes,50 and most currently effective targeted therapies 
interfere with monocyte-derived cytokines, such as TNF and 
IL-6, their signal transduction or cell-cell interaction.51 52 
Recognising which subset of monocytes exhibits particularly 
pathogenic effects is of great importance to develop more 
specific therapies with potentially less safety issues. Our data 
identify non-classical monocytes to be both biomarkers of 
tissue damage as well as direct culprits due to their increased 
potential to differentiate into OCs. Therefore, these cells 
might be attractive therapeutic targets.
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